Scarica l'app Stockscreener
3.92
3.45%
-0.14
Pre-mercato:
3.92
Precedente Chiudi:
$4.06
Aprire:
$4.09
Volume 24 ore:
134.03K
Relative Volume:
0.07
Capitalizzazione di mercato:
$10.52M
Reddito:
-
Utile/perdita netta:
$-4.69M
Rapporto P/E:
-1.6824
EPS:
-2.33
Flusso di cassa netto:
$-3.81M
1 W Prestazione:
+18.79%
1M Prestazione:
+402.56%
6M Prestazione:
+64.46%
1 anno Prestazione:
+64.01%
Intervallo 1D:
$3.82
$4.145
Intervallo di 1 settimana:
$2.75
$4.35
Portata 52W:
$0.64
$4.45
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
Nome
Lixte Biotechnology Holdings Inc
Settore
Industria
Telefono
310 203 2902
Indirizzo
248 ROUTE 25A, EAST SETAUKET
Confronta LIXT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
3.92 | 9.99M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Lixte Biotechnology Holdings Inc Borsa (LIXT) Ultime notizie
What analysts say about Lixte Biotechnology Holdings Inc. stockSky-high profits - Autocar Professional
What drives Lixte Biotechnology Holdings Inc. Equity Warrant stock priceRapid profit acceleration - Autocar Professional
LIXT adds 2 directors after Series B deal; CMO resigns, board reshuffle | LIXTW SEC FilingForm 8-K - Stock Titan
Lixte Biotechnology Holdings Inc. Stock Analysis and ForecastStrongest growth potential - Autocar Professional
What drives Lixte Biotechnology Holdings Inc. stock priceOutstanding capital returns - Autocar Professional
Lixte Biotechnology Holdings Inc. Equity Warrant Stock Analysis and ForecastFree Risk Assessment Services - jammulinksnews.com
Is Lixte Biotechnology Holdings Inc. a good long term investmentAccelerated investment success - jammulinksnews.com
Published on: 2025-07-19 22:24:49 - jammulinksnews.com
LIXTE Biotechnology regains Nasdaq compliance - MSN
What analysts say about Lixte Biotechnology Holdings Inc. Equity Warrant stockSuperior capital gains - jammulinksnews.com
Lixte Biotechnology shares fall 2.38% premarket after regaining Nasdaq compliance. - AInvest
Fluence Energy's Price Target Raised by Barclays: A Shift in Market Dynamics? - AInvest
LIXTE Biotechnology Regains Nasdaq Listing Compliance with $5 Million Financing - AInvest
What analysts say about Lixte Biotechnology Holdings Inc. stock outlookRapid Gain Targets - Newser
Lixte Biotechnology Regains Nasdaq Compliance After Fundraising - The Globe and Mail
Lixte Biotechnology shares fall 3.23% premarket after closing a $5 million private placement. - AInvest
LIXTE Biotechnology Regains Nasdaq Compliance with $5M Financing - AInvest
What makes Lixte Biotechnology Holdings Inc. Equity Warrant stock price move sharplyFree Consultation - beatles.ru
LIXTE Biotechnology Meets Nasdaq Listing Requirement, Shares Down - AInvest
LIXTE Biotechnology's Compliance Win: A Turning Point for Clinical Gains and Stock Stability? - AInvest
LIXTE Biotechnology Holdings, Inc. Regains Nasdaq Compliance Following Successful Capital Raise - Nasdaq
LIXTE Biotechnology regains Nasdaq compliance after $5M funding. - AInvest
LIXTE Biotechnology Holdings Regains Compliance with Nasdaq’s Continued Listing Requirements - GlobeNewswire
LIXTE Biotechnology Holdings Regains Nasdaq Listing Compliance with New Financing - AInvest
LIXTE Secures $6.5M Funding, Maintains Nasdaq Listing While Advancing Cancer Drug Trials - Stock Titan
How Lixte Biotechnology Holdings Inc. Equity Warrant stock performs during market volatility - Newser
What makes Lixte Biotechnology Holdings Inc. stock price move sharplyFree Stock Selection - Newser
How Lixte Biotechnology Holdings Inc. stock performs during market volatilityBreakout Level Watch - Newser
Why Lixte Biotechnology Holdings Inc. Equity Warrant stock attracts strong analyst attentionFree Access to Community - Newser
Why Lixte Biotechnology Holdings Inc. stock attracts strong analyst attentionTop Performer Shortlist - Newser
Lixte Biotechnology Holdings Inc Azioni (LIXT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):